当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-term follow-up of the STOPAGO study
Blood ( IF 21.0 ) Pub Date : 2024-11-04 , DOI: 10.1182/blood.2024025707
Adrien Cottu, Stéphanie Guillet, Jean-François Viallard, Etienne Rivière, Stéphane Cheze, Delphine Gobert, Antoine Neel, Julie Graveleau, Jean-Pierre Marolleau, François Lefrere, Guillaume Moulis, Jean-Christophe Lega, Aline Moignet-Autrel, Ailsa Robbins, Etienne Crickx, Emmanuelle Boutin, Nicolas Noel, Marion Malphettes, Lionel Galicier, Sylvain Audia, Bernard Bonnotte, Olivier Lambotte, Olivier Fain, Mathieu Gerfaud-Valentin, Louis Terriou, Nihal Martis, Anne-Sophie Morin, Antoinette Perlat, Thomas Le Gallou, Frédérique Roy-Peaud, Matthieu Puyade, Thibault Comont, Nicolas Limal, Laetitia Languille, Marc Michel, Bertrand Godeau, Matthieu Mahevas

In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained a sustained response off treatment 4 years after treatment discontinuation.

中文翻译:


STOPAGO 研究的长期随访



在一项开放性前瞻性、多中心研究中,招募了 48 名选定的慢性免疫性血小板减少症患者,这些患者在血小板生成素受体激动剂治疗后 1 年达到完全缓解,其中一半患者在停止治疗 4 年后维持了持续缓解。
更新日期:2024-11-04
down
wechat
bug